Skip to main content
Clinical Trials/NCT05445115
NCT05445115UnknownNot Applicable

DAT: Dyspareunia Alleviation Trial

JSP Innovations1 site in 1 country111 target enrollmentStarted: September 14, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
111
Locations
1
Primary Endpoint
Dyspareunia Alleviation

Study Overview

Brief Summary

Study to evaluate the use of a medical device in relieving collision dyspareunia

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Masking Description

Subjects are blinded as to which arm they are participating in

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Females 18 years of age and older with a diagnosis of collision dyspareunia -

Exclusion Criteria

  • Not provided

Arms & Interventions

Treatment

Experimental

Actual treatment device

Intervention: Mollie device (Device)

Sham

Sham Comparator

Sham/placebo device

Intervention: Mollie device (Device)

Outcomes

Primary Outcomes

Dyspareunia Alleviation

Time Frame: 12 weeks

The Number of Participants with Treatment-Related Adverse Events as Assessed by CTCAE v.4.0, Change from Baseline in Pain Scores on the Visual Analog Scale at 13 Weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
JSP Innovations
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

The Mollie Study, a Study to Evaluate the... | Clinical Trial